9-2039776-ACAGCAGCAGCAGCAGCAGCAGCAGCAGCAG-ACAGCAGCAGCAG
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_003070.5(SMARCA2):c.690_707del(p.Gln233_Gln238del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000153 in 1,596,344 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00031 ( 0 hom., cov: 26)
Exomes 𝑓: 0.00014 ( 0 hom. )
Consequence
SMARCA2
NM_003070.5 inframe_deletion
NM_003070.5 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.94
Genes affected
SMARCA2 (HGNC:11098): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is highly similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. Alternatively spliced transcript variants encoding different isoforms have been found for this gene, which contains a trinucleotide repeat (CAG) length polymorphism. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 9-2039776-ACAGCAGCAGCAGCAGCAG-A is Benign according to our data. Variant chr9-2039776-ACAGCAGCAGCAGCAGCAG-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1366910.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000312 (47/150532) while in subpopulation AFR AF= 0.00066 (27/40908). AF 95% confidence interval is 0.000466. There are 0 homozygotes in gnomad4. There are 28 alleles in male gnomad4 subpopulation. Median coverage is 26. This position pass quality control queck.
BS2
High AC in GnomAd4 at 47 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA2 | NM_003070.5 | c.690_707del | p.Gln233_Gln238del | inframe_deletion | 4/34 | ENST00000349721.8 | NP_003061.3 | |
SMARCA2 | NM_001289396.1 | c.690_707del | p.Gln233_Gln238del | inframe_deletion | 4/34 | NP_001276325.1 | ||
SMARCA2 | NM_001289397.2 | c.690_707del | p.Gln233_Gln238del | inframe_deletion | 4/33 | NP_001276326.1 | ||
SMARCA2 | NM_139045.4 | c.690_707del | p.Gln233_Gln238del | inframe_deletion | 4/33 | NP_620614.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA2 | ENST00000349721.8 | c.690_707del | p.Gln233_Gln238del | inframe_deletion | 4/34 | 5 | NM_003070.5 | ENSP00000265773 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000312 AC: 47AN: 150432Hom.: 0 Cov.: 26
GnomAD3 genomes
AF:
AC:
47
AN:
150432
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000136 AC: 197AN: 1445812Hom.: 0 AF XY: 0.000132 AC XY: 95AN XY: 718568
GnomAD4 exome
AF:
AC:
197
AN:
1445812
Hom.:
AF XY:
AC XY:
95
AN XY:
718568
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000312 AC: 47AN: 150532Hom.: 0 Cov.: 26 AF XY: 0.000381 AC XY: 28AN XY: 73486
GnomAD4 genome
AF:
AC:
47
AN:
150532
Hom.:
Cov.:
26
AF XY:
AC XY:
28
AN XY:
73486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 17, 2023 | This variant is not present in population databases (gnomAD no frequency). This variant, c.690_707del, results in the deletion of 6 amino acid(s) of the SMARCA2 protein (p.Gln233_Gln238del), but otherwise preserves the integrity of the reading frame. This variant has not been reported in the literature in individuals affected with SMARCA2-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | SMARCA2: BS1 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 03, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at